Ling Liu

OverviewAI-generated summary

Ling Liu's research investigates the intersection of metabolism, neurological health, and disease mechanisms. Recent publications explore the restoration of myeloid cell metabolism to reverse cognitive decline in aging and the rescue of cognition across Alzheimer's disease pathologies by restoring hippocampal glucose metabolism. Liu's work also touches on potential therapeutic and prophylactic strategies for prion diseases.

Further research interests include the development of predictive models for posttraumatic epilepsy and the impact of environmental factors on health. Liu has studied alterations in fecal fungal microbiota associated with Crohn's disease and investigated the effects of the pesticide dichlorvos on liver injury in rats, including related toxicity mechanisms. Additionally, Liu has explored dietary interventions, such as the combined effects of low-FODMAPs diets and probiotics on Irritable Bowel Syndrome symptoms.

With a career marked by 183 publications and over 2,961 citations, Liu holds an h-index of 22 and is recognized as a highly cited researcher. Collaborative efforts include work with W. Sue T. Griffin, Srinivas Ayyadevara, Meenakshisundaram Balasubramaniam, and Narasimhappagari Jagadeesh, all at the University of Arkansas for Medical Sciences.

Metrics

• h-index: 22
• Publications: 183
• Citations: 2,961